The Rally in GW Pharmaceuticals Should Continue - Here's How I'd Play It

Let's see how the charts of GWPH are shaping up.

Aphria and Aurora Cannabis: Smoking Out the Differences for Investors

Aurora is trying to ride the momentum of Aphria's earnings report and jump in front of other potential strong reports.

Disciplined Traders Could Go Long Aphria for a Recovery Rally

The charts of the cannabis producer indicate that its shares have found a support level.

Cannabis Firm Aphria Reports Stellar Earnings

I think Aphria is starting to show its potential.

Here's Advice You 'CannTrust': Avoid This Stock

There is no technical reason to go long on beleaguered CTST, and it has not created a bottom, yet.

Interest Lights Up in CannTrust After Talks of Going on the Block

Following growing scandal, CannTrust Holdings is luring bargain shoppers as the stock moves higher after the company announced it's considering selling itself.

Tilray's Getting Smoked: Here's How I Would Play the Struggling Stock

The cannabis company's $4 billion market cap continues to dominate the sector without enough reason.

Village Farms: It Takes an Opportunity - And There's a Terrific One Shaping Up

So many stocks, so much news, so little time. The good news is I'm letting you borrow my shovel.

Zynerba Pharma Looks Like Bad Medicine for Investors

The charts make ZYNE look bearish and not particularly attractive, so avoid.

Village Farms Plays Chess While Traders Play Checkers

The shelf offering isn't a risk. Not having access to it was.